期刊文献+

25-羟基维生素D3在5060岁绝经后女性骨折中的变化 被引量:5

Changes of 25 hydroxy vitamin D_3 in postmenopausal women between 50 and 60 years of age with fractures
下载PDF
导出
摘要 目的探讨在50~60岁绝经后女性骨折中骨代谢指标的变化。方法选择2014年7月~2015年6月因骨折在上海浦东新区公利医院骨科行手术治疗的50~60岁绝经后女性60例[平均年龄为(56.7±3.3)岁],按绝经后年限分为绝经后0~5年[平均年龄为(54.5±3.3)岁]和绝经后5~10年[平均年龄为(58.8±0.9)岁]两组,每组各30例。检测患者身高、体重及25-羟基维生素D3[25-(OH)D3]、骨碱性磷酸酶(BALP)、骨钙素(OC)、Ⅰ型胶原交联羧基末端肽(s-CTX)、Ⅰ型原胶原羧基末端肽(PICP)及尿Ⅰ型胶原氨基末端肽(u-NTX)等骨代谢指标。比较两组间一般情况、骨代谢指标的差异。结果血清25-(OH)D3水平在绝经后5~10年女性中较绝经后0~5年女性降低,差异有统计学意义(P<0.05);血清骨碱性磷酸酶、骨钙素、s-CTX、PICP及u-NTX水平在绝经后0~5年女性与5~10年女性差异无统计学意义(P>0.05)。结论血清25-(OH)D3随着绝经年限的增加而降低,50~60岁绝经后女性应及时补充维生素D3,预防和延缓骨折的发生。 Objective To investigate the changes of bone metabolism markers in postmenopausal women between 50 and 60 years of age with fractures. Methods From July 2014 to June 2015, in Shanghai Pudong New Area Gongli Hospital, 60 postmenopausal women between 50 and 60 years old [average age was(56.7 ±3.3) years] with fractures treated in were selected. The patients were divided into two groups by years after postmenopause, including 30 cases of0-5 years(average: 54.5±3.3) after postmenopause, 30 cases of 5-10 years [average age was(58.8±0.9) years] after postmenopause. All the patients were measured height, weight, and bone metabolism markers, including 25 hydroxy vitamin D3[25-(OH)D3], bone isoenzyme of alkaline phosphatase(BALP), Osteocalcin(OC), C-terminal crosslinking telopeptides of type Ⅰ collagen(u-NTX), type Ⅰ procollagen carboxy-terminal peptide(PICP) and N-terminal crosslinking telopeptides of type Ⅰ collagen(s-CTX). The differences in general and bone metabolism between the two groups were analyzed. Results Serum levels of 25-(OH)D3in 5-10 years after postmenopause group decreased significantly compared with 0-5 years after postmenopause group, the differences were statistically significant(P <0.05). There was no significant difference in serum BALP, OC, s-CTX, PICP, and u-NTX between 0-5 years postmenopause group and 5-10 years after postmenopause group, the differences were not statistically significant(P >0.05). Conclusion Serum levels of 25-(OH)D3decreased while the years after postmenopause increased.Postmenopausal women between 50 and 60 years old should promptly add vitamin D3 in order to prevent and delay the onset of fracture in postmenopausal women between 50 and 60 years old.
出处 《中国医药导报》 CAS 2016年第3期83-86,共4页 China Medical Herald
基金 国家自然科学基金项目(81201367) 上海市浦东新区卫生系统重点学科建设资助项目(PWZx2014-09)
关键词 绝经后女性 骨折 骨代谢指标 25-羟基维生素D3 Postmenopausal women Fracture Bone metabolism markers 25 hydroxy vitamin D3
  • 相关文献

参考文献25

  • 1Hwang JS,Tsai KS,Cheng YM,Chen WJ,Tu ST,Lu KH,Hou SM,Yang SH,Cheng H,Lai HJ,Lei S,Chen JF.Vitamin D status in non-supplemented postmenopausal Taiwan Residents women with osteoporosis and fragility fracture. BMC Musculoskeletal Disorders . 2014
  • 2J. A. Kanis,O. Johnell.??Requirements for DXA for the management of osteoporosis in Europe(J)Osteoporosis International . 2005 (3)
  • 3Khosla S,Atkinson E J,Melton L J,Riggs B L.Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. The Journal of clinical endocrinology and metabolism . 1997
  • 4Zhang Ran,Naughton Declan.Vitamin D in health and disease: Current perspectives. Nutrition Journal . 2010
  • 5Holick Michael F.Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. The American journal of clinical nutrition . 2004
  • 6Felsenfeld Arnold J,Rodríguez Mariano,Aguilera-Tejero Escolástico.Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism. Clinical journal of the American Society of Nephrology : CJASN . 2007
  • 7Marina Vuceljic,Olivera Ilic-Stojanovic,Milica Lazovic.Vitamin D and parathyroid hormone in relation to bone mineral density in postmenopausal women. Vojnosanitetski Pregled . 2012
  • 8Abdellah El Maghraoui,Zhor Ouzzif,Aziza Mounach,Asmaa Rezqi,Lahsen Achemlal,Ahmed Bezza,Saida Tellal,Mohamed Dehhaoui,Imad Ghozlani.Hypovitaminosis D and prevalent asymptomatic vertebral fractures in Moroccan postmenopausal women. BMC Women’s Health . 2012
  • 9闫景刚,段卫华.骨质疏松症治疗药物的研究进展[J].中国医药导报,2015,12(9):34-37. 被引量:19
  • 10张荣伟,刘文静,张珣.维生素D对老龄小鼠脾部分切除术后认知功能的影响及其作用机制研究[J].中国医药导报,2014,11(31):10-13. 被引量:2

二级参考文献51

  • 1赵燕玲,潘子昂,王石麟,王虔,刘京萍,刘忠厚.中国原发性骨质疏松症流行病学[J].中国骨质疏松杂志,1998,4(1):1-4. 被引量:146
  • 2周智广,廖岚,李霞.维生素D对LADA患者胰岛β细胞功能的影响[J].中华内分泌代谢杂志,2005,21(4):411-411. 被引量:10
  • 3Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Organ Tcchn Rep Ser, 1994,843 : 1-129.
  • 4World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complicatlons report of a WHO consultation. Partl. Diagnosis and xlassification of diabetes mellitus. Geneva World Health Organization, 1999,1 ( 7 ) : 151.
  • 5Holick MF, Garabedian M. Vitamin D : photobiology, metabolism, mechanism of action, and clinical applications. In : Favus MJ, ed. Primer on the metabolic bone diseases and disorders ofmineral metabolism . 6th ed. Wash. ington, DC : American Society for Bone and Mineral Research ,2006,129-137.
  • 6Holiek MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr,2004,80( suppl ) :1678S-1688S.
  • 7刘忠厚主编.骨质疏松诊断.中国现代文艺出版社,2011:615.
  • 8张翼,张松,王建平,向斌,周海峰,杨治芳,何伟民,周智广.1α,25二羟维生素D_3对1型糖尿病Th1/Th2平衡的调节作用[J].中国糖尿病杂志,2007,15(9):515-518. 被引量:6
  • 9Littorin B. Lower levels of plasma 25-hydmxyvitamin Damong young aduhs at diagnosis of autoimmune type I diabrtes compared with contnol subjects:results from the nationwide diabetes incidence study in Sweden (DISS)[J]. Diabetologia. 2006,49 ( 12 ) : 2847-2852.
  • 10Judd SE. Vitamin O deficiency and risk for cardiovascular disease [J]. Am J Med Sci ,2009,338( 1 ) : 416-419.

共引文献68

同被引文献44

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部